Tribunal upholds Pharmaceutical Sales Representative expenses as legitimate for tax assessment years

The Tribunal allowed the assessee's appeals and dismissed the revenue's appeals, deleting the disallowance sustained by the Commissioner of Income Tax(Appeals). The judgment affirmed the legitimacy of the claimed Pharmaceutical Sales Representative (PSR) salary and expenses in the trading of pharmaceutical products business for the assessment years 2003-04 and 2005-06. The Tribunal emphasized the necessity and regularity of such expenses in marketing pharmaceutical products, concluding that the adhoc disallowance was unwarranted without proving the expenses as bogus.

---

---

Issues:
- Disallowance of PSR salary and expenses based on adhoc basis
- Genuineness of expenditure claimed by the assessee
- Assessment of expenses in the pharmaceutical products trading business

Analysis:
1. The judgment involves cross-appeals against two separate orders of the Commissioner of Income Tax(Appeals) for the assessment years 2003-04 and 2005-06. The main issue revolves around the adhoc disallowance of Pharmaceutical Sales Representative (PSR) salary and expenses.

2. The assessee, engaged in trading pharmaceutical products, declared a higher gross profit in the relevant year. The Assessing Officer questioned the genuineness of the claimed PSR expenses and salary, considering the percentage of expenses in comparison to total sales. The Assessing Officer disallowed a significant portion of the expenses, leading to the appeal.

3. The assessee argued that the expenses on Medical Representatives are essential for the business and should not be subject to adhoc disallowance. The Commissioner of Income Tax(Appeals) partially allowed the claim but restricted it to 28% of sales instead of the 32.4% claimed by the assessee.

4. The Tribunal noted that no investigation was conducted by the Assessing Officer to verify the genuineness of the expenses. It was recognized that marketing pharmaceutical products involves substantial expenses, and the necessity of such expenses was not disputed. The Tribunal emphasized that without proving the claim as bogus, disallowing it solely based on being excessive is unjustified.

5. The Tribunal highlighted that the payments to Medical Representatives were not disputed, and the expenses were part of the regular business operations. Therefore, an adhoc disallowance was deemed unwarranted. The Tribunal accepted the assessee's explanation regarding the nature of expenses in the pharmaceutical marketing business.

6. Ultimately, the Tribunal allowed the appeals of the assessee and dismissed the revenue's appeals. The disallowance sustained by the Commissioner of Income Tax(Appeals) was deleted, affirming the legitimacy of the claimed expenses in the trading of pharmaceutical products business for both assessment years.

This detailed analysis outlines the key legal points and arguments presented in the judgment regarding the disallowance of PSR salary and expenses, the genuineness of the claimed expenditure, and the assessment of expenses in the pharmaceutical trading business.

---